Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)
Clinical trial NCT00598806 · COMPLETED
Trial details
- NCT number
- NCT00598806
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2012-01-01
- Enrollment
- 812
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.